These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4150813)
41. The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle. MacDonald RS; Swan PB Biochim Biophys Acta; 1986 Feb; 880(2-3):153-60. PubMed ID: 3942787 [TBL] [Abstract][Full Text] [Related]
42. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent. Timms AR; Kelly LA; Ho RS; Trapold JH Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622 [No Abstract] [Full Text] [Related]
43. Effects of nafenopin, diphenylhydantoin, phenobarbitone and some acetylenes on body composition: is there a relationship between decreased carcass lipid and increased liver size and induction of drug metabolizing enzymes? Arch JR; Green A; Cawthorne MA Int J Obes; 1980; 4(1):1-10. PubMed ID: 7390696 [TBL] [Abstract][Full Text] [Related]
44. Hepatic effect of two hypolipidemic drugs in rats. Magnusson G; Magnusson O Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535 [TBL] [Abstract][Full Text] [Related]
45. [Effect of various drugs on lipid content and drug metabolizing enzymes in rat liver following experimentally induced fatty degeneration]. Elies W; Heni N; Remmer H Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):317-8. PubMed ID: 4253759 [No Abstract] [Full Text] [Related]
46. Differential increase of hepatic peroxisomal, mitochondrial and microsomal carnitine acyltransferases in clofibrate-fed rats. Markwell MA; Bieber LL; Tolbert NE Biochem Pharmacol; 1977 Sep; 26(18):1697-702. PubMed ID: 901588 [No Abstract] [Full Text] [Related]
48. Acute interaction of drugs. I. The effect of volatile anesthetics on the kinetics of aniline hydroxylase and aminopyrine demethylase in rat hepatic microsomes. Korten K; Van Dyke RA Biochem Pharmacol; 1973 Sep; 22(17):2105-12. PubMed ID: 4733666 [No Abstract] [Full Text] [Related]
49. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria. Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871 [No Abstract] [Full Text] [Related]
50. Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein. Meijer DK; Vonk RJ; Keulemans K; Weitering JG J Pharmacol Exp Ther; 1977 Jul; 202(1):8-21. PubMed ID: 874820 [No Abstract] [Full Text] [Related]
51. [The mechanism of liver enlargement after treatment with different doses of phenobarbital]. Paulini K; Beneke G; Kulka R Beitr Pathol; 1971 Jun; 143(3):283-94. PubMed ID: 5559021 [No Abstract] [Full Text] [Related]
52. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs. Reddy JK J Histochem Cytochem; 1973 Nov; 21(11):967-71. PubMed ID: 4587529 [No Abstract] [Full Text] [Related]
53. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships. Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380 [TBL] [Abstract][Full Text] [Related]
54. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect. Azarnoff DL; Svoboda DJ Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540 [No Abstract] [Full Text] [Related]
55. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals. Suzuki K; Aono S; Nakatani H Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146 [No Abstract] [Full Text] [Related]
56. The peroxisome proliferation-associated polypeptide in rat liver. Reddy JK; Kumar NS Biochem Biophys Res Commun; 1977 Aug; 77(3):824-9. PubMed ID: 901515 [No Abstract] [Full Text] [Related]
57. Lentysine: a new hypolipidemic agent from a mushroom. Rokujo T; Kikuchi H; Tensho A; Tsukitani Y; Takenawa T; Yoshida K; Kamiya T Life Sci; 1970 Apr; 9(7):379-85. PubMed ID: 5463059 [No Abstract] [Full Text] [Related]
58. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Lalwani ND; Fahl WE; Reddy JK Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818 [TBL] [Abstract][Full Text] [Related]
59. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate. Bondesson G; Högberg T; Misiorny A; Stjernström NE Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013 [No Abstract] [Full Text] [Related]